Motor Neurone Disease Trial, Recruiting NCT07224256 Sponsor: Neuralink Corp Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07224256
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult who has been diagnosed with ALS, PLS, stroke, or a spinal cord injury
  • You have severe difficulty speaking
  • You have significant difficulty using your arms and/or hands
  • Doctors expect you to live for at least 12 more months
  • You are able to communicate in English
  • You have a caregiver who is reliably available to support you

Who may not be able to join:

  • You have health conditions that make surgery or procedures particularly risky for you (confirm with trial site)
  • You have a Body Mass Index (BMI) over 40, which is considered morbid obesity
  • You have a history of seizures or epilepsy that has been difficult to control
  • You have a history of diabetes that has been difficult to control
  • You need MRI scans regularly as part of managing an existing health condition
  • You have a weakened immune system, whether from a condition you were born with or one you developed
  • You have a diagnosed psychiatric or psychological condition
  • A brain MRI scan has shown bleeding, a tumor, or unusual brain structure (confirm with trial site)
  • You have any other condition that the trial doctor believes would make it unsafe for you to take part or undergo the implant procedure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nader Pouratian, MD, University of Texas Southwestern Medical Center

Phone: +1 (650) 250-0520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Neuralink Corp
Registry
ClinicalTrials.gov
Start date
3 October 2025
Est. completion
1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Device-Related Adverse Events (AE); Procedure-Related Adverse Events (AE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov